drugset / Trial / NCT00168896
A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage
Phase 2/3
Unknown
286 enrolled
Charite University, Berlin, Germany
Aventis Pharmaceuticals · collabPfizer · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
Comparison of two combination chemotherapies in the treatment of patients with SLCL
Timeline
- Start
- 2001-10
- Primary completion
- —
- Completion
- 2006-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | — | — |
| Subject | Etoposide | Small molecule | — | — |
| Subject | Irinotecan | Small molecule | — | — |